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Abstract
Aims/hypothesis—Levels of ideal cardiovascular health (ICH) and incident type 2 diabetes 
mellitus have not been examined in a multiethnic population. We assessed the total and race/
ethnicity-specific incidence of diabetes based on American Heart Association (AHA) ICH 
components.
Methods—Incident diabetes was assessed among 5,341 participants in the Multi-Ethnic Study of 
Atherosclerosis without prevalent diabetes between 2002 and 2012. ICH components (total 
cholesterol, BP, dietary intake, tobacco use, physical activity and BMI) were assessed at baseline 
and participants were categorised as having ideal, intermediate or poor cardiovascular health, as 
defined by the AHA 2020 impact goals. We developed a scoring system based on the number of 
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ICH components (0–1 ‘poor’, 2–3 ‘intermediate’, and ≥4 ‘ideal’). HRs were calculated using Cox 
models.
Results—During a median follow-up of 11.1 years, we identified 587 cases of incident diabetes. 
After multivariable adjustment, participants with 2-3 and ≥4 ICH components vs 0-1 components 
had a 34% lower (HR 0.66; 95% CI 0.54, 0.80) and a 75% lower (HR 0.25; 95% CI 0.18, 0.35) 
diabetes incidence, respectively. There were significant differences by race/ethnicity: African-
American and Hispanic-American participants with ≥4 ICH components had diabetes incidence 
rates per 1,000 person-years of 5.6 (95% CI 3.1, 10.1) and 10.5 (95% CI 6.7, 16.4), respectively, 
compared with 2.2 (95% CI 1.3, 3.7) among non-Hispanic white Americans.
Conclusions/interpretation—Meeting an increasing number of AHA 2020 impact goals for 
dietary intake, physical activity, smoking, BP, cholesterol and BMI was associated with a dose-
dependent lower risk of diabetes with significant variation by race/ethnicity.
Keywords
Adiposity; Blood pressure; Cholesterol; Diabetes; Dietary intake; Glucose; Ideal cardiovascular 
health; Physical activity; Race/ethnicity; Smoking
Introduction
In 2010, the American Heart Association (AHA) published 2020 impact goals for 
cardiovascular health promotion with the aim of improving cardiovascular health and 
reducing deaths from cardiovascular disease (CVD) and stroke by 20% by the year 2020 [1]. 
As part of this initiative, the AHA defined the concept of ideal cardiovascular health (ICH), 
identifying seven health factors or behaviours that have been associated with healthy ageing 
without cardiovascular and other chronic diseases. These include total cholesterol, BP, 
fasting plasma glucose, dietary intake, tobacco use, physical activity and BMI (Table 1) [1]. 
Many cardiovascular risk factors also confer a high risk of incident type 2 diabetes mellitus, 
including physical inactivity, obesity, unhealthy dietary habits, and, to a lesser extent, 
elevated BP and dyslipidaemia [2]. CVD is the leading cause of morbidity and mortality 
among individuals with diabetes. Individuals with diabetes have a threefold increase in 
cardiovascular mortality compared with those without diabetes [3]. Given the shared risk 
factors and burden of both CVD and diabetes in the USA, it is important to determine 
whether the 2020 impact goals for ICH will impact diabetes incidence.
Adherence to the various components of ICH varies by ethnicity [4–6]. While one study 
among American Indians suggested that individuals who met a greater number of ICH goals 
had a reduced risk of incident diabetes [6], to our knowledge this hypothesis has not been 
assessed in a multiethnic population.
We tested the hypothesis that participants with higher levels of cardiovascular health are less 
likely to develop diabetes based on the AHA metric in four racial/ethnic groups in the Multi-
Ethnic Study of Atherosclerosis (MESA). We additionally examined whether the association 
of individual or overall cardiovascular health components with incident diabetes varies by 
race/ethnicity.
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Methods
MESA is a population-based sample of 6,814 men and women from four ethnic groups: non-
Hispanic whites (NHW; 38%), African-Americans (AA; 28%), Chinese-Americans (CA; 
12%) and Hispanic-Americans (HA; 22%). Participants were aged 45–84 years at baseline; 
those who reported a medical history of heart attack, angina, coronary revascularisation, 
pacemaker or defibrillator implantation, valve replacement, heart failure or cerebrovascular 
disease were excluded. Details of sampling and recruitment have been published elsewhere 
[7]. The study was approved by the institutional review boards of the six participating 
institutions.
During the baseline examination (2000–2002), standardised questionnaires and calibrated 
devices were used to obtain participant data including: demographics, occupation, level of 
education, tobacco use, alcohol consumption, medical conditions and current prescription 
medication. Race/ethnicity was assessed by self-report and categorised as NHW, non-
Hispanic Black (AA), Hispanic (HA) or Chinese (CA). Current occupational status was 
classified into ten categories: homemaker, employed (full time, part time, on leave due to ill 
health, or on leave due to non-health related issues), unemployed (<6 or >6 months) and 
retired (not working, working or volunteering). Education was classified into one of the 
following five categories: less than high school, completed high school, some college/
technical school certificate or associate degree, bachelor's degree, and graduate or 
professional school. Smoking history was obtained using a questionnaire developed from the 
third National Health and Nutrition Examination Survey (NHANES III), the National Health 
Interview Survey (NHIS) and the Atherosclerosis Risk in Communities Study (ARIC). 
Current alcohol use was assessed as a binary variable by asking participants whether they 
presently drank alcoholic beverages. Calibrated devices were used to measure participants' 
weight, waist circumference and height; BMI was calculated as weight in kilograms divided 
by the square of height in metres. Resting seated BP was measured three times using a 
Dinamap Pro 100, automated oscillometric sphygmomanometer (Critikon, Tampa, FL, 
USA); the last two measurements were averaged for analysis.
Physical activity
The MESA Typical Week Physical Activity Survey, adapted from the Cross-Cultural 
Activity Participation Study, was used to assess physical activity [8]. We used the intentional 
exercise variable (sum of walking for exercise, sports/dancing, and conditioning in 
metabolic equivalent of task [MET] min/week) with the following categorisation: ‘poor’ <3 
MET min/week, ‘intermediate’ 3–449 MET min/week, ‘ideal’ ≥450 MET min/week. Given 
that 3 METs and 6 METs are the lower limits for moderate and vigorous intensity physical 
activity, our MET min/week categorisation is consistent with the minutes per week measure 
in the AHA guidelines [1].
Dietary assessment
Dietary intake was assessed using the MESA food frequency questionnaire, a self-
administered modified-Block-style 120-item questionnaire adapted from the Insulin 
Resistance Atherosclerosis Study instrument [7]. The MESA questionnaire had some slight 
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differences compared with the 2020 guidelines regarding units of servings, requiring 
modification of the metrics. Components of the modified ideal diet score are: fruits and 
vegetables, ≥4.5 cups (equivalent to 1.08 l)/day; fish, two or more 98 g (3.5 ounce) servings 
per week (non-fried); fibre-rich whole grains, three or more 28 g (1 ounce)-equivalent 
servings/day; sodium, <1,500 mg/day; sugar-sweetened beverages, ≤1,884 kJ (1008 g)/
week. Participants were given 1 point per dietary component at goal for a total score ranging 
from 0 to 5. Participants were classified as ideal (4-5 of 5 metrics), intermediate (2-3 of 5 
metrics) or poor (0-1 of 5 metrics).
Laboratory assessment
Fasting blood samples were drawn and processed using a standardised protocol and sent to 
central laboratories at the Collaborative Studies Clinical Laboratory at Fairview University 
of Minnesota Medical Center (Minneapolis, MN, USA) for measurement of glucose, 
cholesterol and estimated glomerular filtration rate [9]. Serum glucose was measured by rate 
reflectance spectrophotometry using thin-film adaptation of the glucose oxidase method on a 
Vitros analyser (Ortho Clinical Diagnostics, Rochester, NY, USA). Total cholesterol was 
measured using a cholesterol oxidase method (Roche Diagnostics, Indianapolis, IN, USA) 
on the Roche Cobas Fara centrifugal analyser. Serum creatinine was measured by rate 
reflectance spectrophotometry using thin-film adaptation of the creatinine amidinohydrolase 
method on the Vitros analyser (Ortho Clinical Diagnostics) and calibrated to Cleveland 
Clinic. Creatinine was used to estimate glomerular filtration rate based on the Chronic 
Kidney Disease Epidemiology Collaboration equation [10].
Cardiovascular health
Cardiovascular health was assessed among the seven baseline metrics: smoking status, diet, 
physical activity, BMI, serum cholesterol and BP, with the addition of fasting plasma 
glucose in the sensitivity analyses [6]. Each baseline metric was scored and categorised as 
poor, intermediate or ideal, as specified by AHA recommendations, with consideration of 
medication use (i.e. antihypertensive, lipid-lowering, glucose-lowering) where appropriate 
[1]. Points were allocated for each of the seven baseline metrics with scores of 0 (poor or 
intermediate) or 1 (ideal) for each health behaviour (diet, smoking, physical activity, BMI) 
and health factor (BP, blood sugar, total cholesterol) (Table 1). We summed the metrics into 
the following categories: poor (0–1), intermediate (2–3) and ideal (≥4) levels of 
cardiovascular health. Second, we used a previously developed scoring system [4] in which 
each cardiovascular health metric was given a point score of 0, 1 or 2 to represent poor, 
intermediate or ideal health (Table 1), respectively. A total cardiovascular health score 
(excluding glucose) ranging from 0 to 12 was calculated as the sum of the individual 
cardiovascular health component scores. This score was classified into three levels as 
inadequate (0–4), average (5–8) or optimal (9–12) cardiovascular health.
Diabetes definition
Among those without prevalent baseline diabetes, individuals newly using glucose-lowering 
medication or having fasting glucose ≥7 mmol/l (126 mg/dl) at one of the four subsequent 
examinations (the last follow-up visit occurring in 2010-2012) were considered to have 
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incident diabetes [11]. We defined time of incident diabetes as the midpoint between the last 
examination without diabetes and the examination at which diabetes developed.
We were unable to distinguish between type 1 diabetes and type 2 diabetes, but in this age 
range, incident type 1 diabetes is extremely uncommon, so we assumed a predominance of 
type 2 diabetes in our population.
Statistical analysis
We excluded participants with diabetes at baseline (n=883), missing diabetes status at their 
last follow-up (n=57) or missing data on baseline covariates (n=526). The 583 participants 
excluded due to missing diabetes and covariate status had a higher percentage of AA, higher 
BMI, higher smoking, lower education, less physical activity and a higher rate of incident 
diabetes (p<0.05 for all comparisons) (electronic supplementary material [ESM] Table 1). 
Descriptive statistics were used to compare the baseline characteristics of all participants 
(non-stratified) and by race/ethnicity, using appropriate parametric or non-parametric tests 
for continuous variables and the χ2 test for categorical variables. Among the seven ICH 
components, we did not consider the blood glucose metric in the main analysis, as diabetes 
was the endpoint of interest. We used the other six components of the ICH score [6] to 
develop the two aforementioned scoring systems for ICH and total cardiovascular health. 
Last, we assessed the association between individual cardiovascular health components and 
incident diabetes by comparing participants with intermediate or ideal status with those with 
poor status (reference group) at baseline for each of the six factors. Unadjusted diabetes 
incidence rates for cardiovascular health scores were calculated using person–time analysis 
assuming a Poisson distribution. Participants were censored at the last attended follow-up 
examination. Incidence rate ratios were assessed using the logrank test. Cox proportional 
hazards modelling was used to estimate HRs associated with the aforementioned 
classifications. Covariates in adjusted analyses included baseline study site, age, sex, race/
ethnicity, education, occupational status, alcohol use and estimated glomerular filtration rate. 
The baseline number of cardiovascular health components and cardiovascular health values 
categorised as poor, intermediate or ideal were evaluated to estimate the proportion of cases 
in the population that might be attributable to suboptimal levels of cardiovascular health 
(population-attributable risk). The population-attributable risk was calculated using the 
formula p(RR−1)/(1+p[RR−1]), where p is the prevalence of individuals not in the low-risk 
group and RR (risk ratio, HR) is the associated multivariable-adjusted relative risk of those 
individuals. Upper and lower 95% CIs of the population-attributable risk were derived using 
this formula and the upper and lower 95% CI estimates of the multivariable-adjusted risk 
ratio [12]. Given that the association of cardiovascular health attainment with diabetes risk 
may differ by age, sex and race/ethnicity, we tested for interaction by these factors with each 
cardiovascular health measure by inserting an interaction term in the model and using the 
likelihood ratio test. Statistical significance was defined as two-sided α<0.05. Analyses were 
performed using Stata 13.1 software (StataCorp, College Station, TX, USA).
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Results
Characteristics of the cohort
The baseline characteristics of participants stratified by race/ethnicity revealed that 
characteristics were different across race/ethnicity. HA and AA participants had significantly 
higher BMI, systolic BP and fasting glucose and lower levels of ICH components compared 
with NHW (Table 2).
Incidence of diabetes
During a median follow-up of 11.1 years, 587 participants developed incident diabetes 
(incidence rate 11.1 per 1,000 person–years). Incidence rates were highest among HA (15.3) 
and AA (12.3) (Table 2). Participants who developed diabetes had higher baseline BMI (30.8 
vs 27.5 kg/m2), systolic BP (130 vs 125 mmHg) and fasting plasma glucose (5.61 vs 4.88 
mmol/l,[101 vs 88 mg/dl]) (comparisons p<0.0001; ESM Table 2).
Diabetes incidence rates per 1,000 person-years in participants with 0-1, 2-3 or ≥4 ICH 
components were 18.9 (95% CI 15.9, 22.4), 12.1 (95% CI 11.0, 13.3) and 4.4 (95% CI 3.4, 
5.7), respectively, with a risk ratio of incident diabetes per category of 0.52 (95% CI 0.46, 
0.60) (Table 3). Incident diabetes rates decreased for every additional ICH component 
achieved in the overall cohort and each racial/ethnic group (Table 3).
ICH and incident diabetes
The unadjusted and adjusted HRs for incident diabetes associated with baseline ICH are 
presented in Table 4. After adjustment, the HR for 5-6 vs 0 individual ICH components was 
0.17 (95% CI 0.08, 0.38), and the HRs for intermediate or ideal categories compared with 
the poor cardiovascular health category was 0.66 (95% CI 0.54, 0.80) and 0.25 (95% CI 
0.18, 0.35), respectively. Among the individual cardiovascular health components, ideal vs 
poor status was associated with a decreased risk of incident diabetes for BP (HR 0.53; 95% 
CI 0.42, 0.68) and BMI (HR 0.25; 95% CI 0.19, 0.33) in adjusted analyses and for physical 
activity (HR 0.82; 95% CI 0.67, 1.00) in unadjusted analyses (Table 5). We found no 
consistent evidence of interactions between cardiovascular health components and age or sex 
(ESM Table 3). Sensitivity analyses conducted using the total cardiovascular health score 
(ESM Tables 4-6, ESM Figure 1), including participants with missing dietary data (n=5,817) 
(ESM Table 7), the addition of baseline glucose as a covariate (ESM Table 8), or the 
inclusion of glucose as a cardiovascular health component (seven components) (ESM Table 
9) revealed similar findings and remained significant. Ideal (<5.6 mmol/l [<100 mg/dl]) vs 
intermediate (5.6–7.0 mmol/l [100–<126 mg/dl]) baseline blood glucose categories were 
associated with an 87% reduction in risk (ESM Table 10).
Cardiovascular health and incident diabetes by race/ethnicity
There were significant differences by race/ethnicity in the association of baseline ICH 
components with risk of diabetes (all p<0.01; ESM Table 2). In Table 4, ideal vs poor 
cardiovascular health was associated with a greater reduction in diabetes risk in NHW and 
CA (87% and 88%) vs AA and HA (66% and 50%) (Fig. 1). Among the individual 
cardiovascular health components, ideal vs poor status was significant for: BP in NHW, CA 
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and AA, with the greatest association of risk reduction in NHW (HR 0.36; 95% CI 0.23, 
0.55); and BMI in all ethnicities, with no significant difference among the race/ethnicities 
(Table 5).
Population-attributable diabetes risk
We evaluated diabetes risk by baseline number of cardiovascular health components and 
categories at baseline, compared with all others not in that group (Table 6). The baseline 
number of ICH components 2, 3, 4 or ≥5 were associated with a 30%, 23%, 63% and 66% 
lower diabetes incidence, respectively. Individuals in the ICH category at baseline (23%) had 
a 65% lower incidence of diabetes, and three in five new cases of diabetes appeared 
attributable to not being in the ICH group at baseline.
Discussion
In this large, contemporary, multiethnic cohort study, the presence of an increasing number 
of ICH components at baseline was strongly and inversely associated with incident diabetes. 
The effect of ICH was graded: participants with intermediate or ideal vs poor cardiovascular 
health had a 34% and 75% lower diabetes incidence, respectively, which is consistent with 
previous studies [12, 13]. In analyses stratified by race/ethnicity, the greatest reductions in 
diabetes risk based on ICH components were seen in NHW and CA. Overall, three out of 
five cases of diabetes in this middle-aged population appeared attributable to not having ICH 
at baseline. If these associations are causal, diabetes could be prevented by attainment of at 
least four ICH components. Compared with previous studies examining the combined 
effects of multiple risk factors on the incidence of diabetes [12, 13], we used a novel AHA 
concept that may be more adapted for translation of prevention policies that encompass both 
diabetes and CVD into practice. Public health interventions over the last 30 years have led to 
plateauing of diabetes incidence among NHW, but among AA and HA there remains a 
continued ascent in incident diabetes [14]. Overall, these findings support promotion of and 
adherence to the AHA 2020 impact goals to lower diabetes incidence among all races/
ethnicities, but emphasise the importance of tailoring interventions to prevent diabetes in 
racial/ethnic minorities given the observed disparities.
ICH goals and incident diabetes
Our study is the first multiethnic analysis to assess the association of baseline ICH with 
incident diabetes. A previous study among American Indians showed that participants who 
achieved 0–1 ICH goals compared with those who achieved 2–3 or ≥4 ICH goals had a 60% 
and 89% lower odds of developing diabetes [6], compared with the 34% (2-3 ICH goals) and 
75% (≥4 ICH goals) lower diabetes incidence compared with 0-1 ICH goals in our study. 
The observed difference is likely related to the inclusion of glucose among the ICH 
components in the Fretts et al study [6], whereas we excluded glucose in our main analysis, 
as it is directly in the causal pathway to diabetes. However, sensitivity analyses including 
glucose as a component of cardiovascular health revealed a similar order of risk reduction: 
−61% and −86% lower diabetes risk of participants in the intermediate or ideal category 
compared with those in the poor category. In the Cardiovascular Health Study [12], among 
older US adults (age >65 years) low-risk lifestyle groups defined by physical activity, dietary 
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score, smoking, alcohol use, BMI and waist circumference were associated with an 89% 
reduction in diabetes risk with five low-risk lifestyle factors, similar to our 89% reduction in 
risk with ≥4 ICH components. In the National Institutes of Health–American Association of 
Retired Persons (NIH-AARP) Diet and Health Study, Reis et al [13] examined the 
association of low-risk lifestyle factors including BMI, diet, smoking, moderate alcohol 
consumption and regular physical activity with incident diabetes (self-report). The ORs for 
incident diabetes over 11 years in those with all five low-risk lifestyle factors at baseline 
were 0.28 (95% CI 0.23, 0.34) and 0.16 (95% CI 0.10, 0.24) for men and women, 
respectively, suggesting sex differences. These findings were similar to our ICH category 
(≥4 ICH components), and the test for effect modification by sex in our analysis was non-
significant. We extended these previous findings by assessing a multiethnic population, as 
the Cardiovascular Health Study is 88.6% NHW and the NIH-AARP Diet and Health Study 
is 94.3% NHW, thus limiting generalisability of the finding to other racial/ethnic groups.
Racial/ethnic differences
Consistent with previous US population-based studies [15], AA and HA in the MESA cohort 
had lower levels of ICH at baseline. We observed significant variation of the association of 
higher ICH with lower incident diabetes among racial/ethnic groups. NHW and CA had 
greater magnitudes of risk reduction and better cardiovascular health compared with AA and 
HA (p<0.01). The lower prevalence of ICH [15], combined with lower magnitude of 
diabetes reduction with ICH in AA and HA, provide a potential explanation and intervention 
target for the disparities in diabetes prevalence among these groups.
Individual AHA cardiovascular health goals and incident diabetes
Impaired glucose tolerance, impaired fasting glucose and HbA1c in the prediabetic range 
(5.7-6.4% [38.8 – 46.4 mmol/mol]) are associated with the greatest risk of diabetes, as they 
reflect derangements in the pathway from normal glucose tolerance to diabetes [16, 17]. 
Among risk factors not directly in the causal pathway, BMI was the predominant risk factor 
for diabetes, with a 48% and 77% lower diabetes risk for overweight BMI and normal BMI, 
respectively, vs obese BMI. This is consistent with previous studies showing increasing BMI 
as the primary risk factor increasing diabetes prevalence in the USA over the last 30 years 
[18]. In the Diabetes Prevention Program (DPP), sustained weight loss was the primary 
driver of reduced diabetes risk and cardiometabolic improvement [19]. In US populations, 
the imbalance between caloric intake and energy expenditure is the primary driver of 
increasing BMI and may have even greater importance in some racial/ethnic groups due to a 
reduction in baseline energy expenditure [20].
Among the other individual components, normal BP (<120/<80 mmHg) was associated with 
a 47% diabetic risk reduction in the overall cohort vs elevated BP (>140/90 mmHg), with 
NHW showing the greatest reduction in diabetes risk compared with the other racial/ethnic 
groups. In a prior study, BP elevation was associated with incident diabetes in AA and NHW 
in age-adjusted analyses, but the association was nonsignificant among AA after adjustment 
for other diabetic risk factors [21]. This corresponded with an earlier study in which mean 
BP was significantly correlated with fasting plasma insulin and rate of glucose disposal in 
whites, but not in blacks [22]. Contrary to the prior literature, in our study, BP remained 
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significant in all racial/ethnic groups except for HA. Elevated BP and diabetes can both be 
mediated by inflammation and decreased antioxidants, which may partly explain the 
association between BP and diabetes [23].
Physical activity is beneficial in reducing incident diabetes in the majority of NHW 
observational studies [24]. There is a scarcity of data on physical activity alone and incident 
diabetes in racial/ethnic minority groups in the USA. In observational studies, AA and HA 
have lower physical activity levels than NHW, independently of social class [25]. In a study 
of AA women, vigorous physical activity alone was associated with a dose-dependent 
reduction in risk of incident diabetes [26]. Further studies to understand the impact of 
physical activity on diabetes risk are warranted in US racial/ethnic minority groups.
Smoking, dietary intake and total cholesterol were not individually associated with incident 
diabetes in our analysis. In large multiethnic meta-analyses, smoking increased the risk of 
diabetes, with a pooled adjusted relative risk of 1.4 (95% CI 1.3, 1.6) vs non-smokers [27]. 
Data on causal inference between smoking and the development of diabetes are inconsistent: 
some studies show impairment in insulin sensitivity [28, 29] and glucose tolerance [29, 30], 
while other studies conclude that causal inference is not likely, after adjusting for 
confounders including age and BMI [31]. Further complicating the relationship are data 
from smoking cessation studies showing worsened glucose metabolism in those with 
diabetes in the first 1–3 years after smoking cessation [32], and an increased risk of incident 
diabetes in smokers without diabetes who quit, with subsequent improvement to similar risk 
of that of non-smokers over 12 years [33]. Smokers are also more likely to have unhealthy 
behaviours and low socioeconomic status, which contribute to the risk of diabetes [27].
While there was no association of dietary intake with incident diabetes, we are unable to 
draw definitive conclusions because only 1.5% of participants had baseline ideal dietary 
intake. Components of the AHA diet score including fruits and vegetables, fibre-rich whole 
grains, decreased sodium and sugar-sweetened beverage intake, and adherence to 
components of the Dietary Approaches to Stop Hypertension (DASH) and the 
Mediterranean diet have been associated with improvements in glucose metabolism and 
decreased incident diabetes [34–38]. A meta-analysis of ten large prospective studies found 
that dietary patterns similar to the AHA dietary recommendations were associated with a 
66% reduction in diabetes [39]. Notably, the AHA diet score does not take into account 
other forms of dietary intake associated with decreases in diabetes and CVD risk including 
dairy consumption [40–42] and glycaemic index/load [43–45].
We found no significant overall association between total cholesterol and incident diabetes 
in our analysis. Components of the lipid profile including triacylglycerols, HDL and non-
esterified fatty acids, have been associated with incident diabetes [46].
Among the AHA cardiovascular health components, BMI is well studied in US racial/ethnic 
minorities, in whom weight loss has been shown to reduce diabetes risk [19]. The 
association of individual components including BP, physical activity, smoking, total 
cholesterol and dietary intake with diabetes has previously revealed inconsistent findings 
and would benefit from further study among US racial/ethnic minorities.
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Strengths and limitations
Strengths of our analysis include a moderately large, socioeconomically diverse, multiethnic 
US population with over a decade of follow-up, allowing broad generalisability of our 
findings. We used validated questionnaires and documentation of diabetes over time with 
fasting glucose, medication use and self-reported physician diagnosis. Nevertheless, there 
are several potential limitations. Physical activity and diet were self-reported; thus, 
misclassification and residual confounding by these variables may have occurred. The time 
frame queried was the last month prior to the baseline visit; so, depending on the season of 
examination, the prior month may not be representative of customary physical activity and 
dietary intake. Sample sizes varied for the racial/ethnic groups, with power implications for 
detecting significant racial/ethnic interactions in stratified analyses, but the interaction terms 
for categories of cardiovascular health were significant (p<0.01). As previously mentioned, 
we were unable to distinguish between type 1 diabetes and type 2 diabetes, so we assumed a 
predominance of type 2 incident diabetes in our population.
Conclusions
Our study showed that increasing levels of ideal and overall cardiovascular health within the 
guidelines set forth by the AHA 2020 impact goals may reduce the burden of diabetes in the 
USA. Unfortunately, less than one in four participants in our overall cohort and less than one 
in six racial/ethnic minorities attained ≥4 ICH components, which is similar to findings in 
other studies [4, 5, 15]. Given the racial/ethnic differences in attainment of ICH, the lower 
magnitude of risk reduction with ICH and the increased burden of diabetes in racial/ethnic 
minorities, further research on promotion, attainment and ethnic differences of ICH in US 
racial/ethnic minority groups is of paramount importance to lower the risk of CVD and 
diabetes.
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Fig. 1. 
Diabetes Incidence HRs for ICH. ICH was classified as poor (0–1 ICH components) 
(referent group, HR = 1), intermediate (2–3 ICH components) and ideal (≥4 ICH 
components) cardiovascular health. Circles, all races/ethnicities; squares, NHW participants; 
up-pointing triangles, CA participants; down-pointing triangles, AA participants; diamonds, 
HA participants. Cox modelling and logrank test (p for trend) with statistical significance for 
*p<0.05, **p<0.01, ***p<0.001 and ****p<0.0001
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Table 1
Total cardiovascular health score and definitions of cardiovascular healtha
Goal/metric Poor health Intermediate health Ideal health
Current smoking, months Yes Former ≤12 Never or quit ≥12
Total cholesterol, mmol/l (mg/dl) ≥6.21 (≥240) 5.18-6.18 (200-239), or treated to goal <5.18 (<200)
BP, mmHg Systolic ≥140 or 
diastolic ≥90
Systolic 120-139 or diastolic 80-89, or 
treated to goal
<120 /<80
BMI, kg/m2 ≥30 25.0-29.9 <25
Physical activity, MET min/weekb <3 3–449 ≥450
Healthy diet score, componentsc 0-1 2-3 4-5
Fasting plasma glucose, mmol/l (mg/dl)d ≥7.0 (≥126) 5.6-6.9 (100-125), or treated to goal <5.6 (<100)
Points for ICH score per metric 0 0 1
Points for total cardiovascular health score per metric 0 1 2
aAdapted from the AHA's strategic planning task force and statistical committee 2020 guidelines1
bAdapted for MESA: MET min/week
cAdapted for MESA: fruits and vegetables, ≥ 1.08 l (4.5 cups)/day; fish, two or more 98 g (3.5 ounce) servings per week (non-fried); fibre-rich 
whole grains, three or more 28 g (1 ounce)-equivalent servings/day; sodium, <1,500 mg/day; sugar-sweetened beverages, ≤1,884 kJ (1008 g)/week
d
Fasting plasma glucose was not used in the main analysis but was considered in the sensitivity analyses.
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